KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $297,000 | -29.5% | 21,770 | -5.2% | 0.00% | 0.0% |
| Q2 2022 | $421,000 | +6.0% | 22,970 | -6.9% | 0.00% | +50.0% |
| Q1 2022 | $397,000 | +19.2% | 24,671 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $333,000 | -24.0% | 23,757 | +1.5% | 0.00% | -33.3% |
| Q3 2021 | $438,000 | -12.2% | 23,409 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $499,000 | -22.8% | 23,952 | +4.8% | 0.00% | -25.0% |
| Q1 2021 | $646,000 | +65.6% | 22,856 | +91.2% | 0.00% | +100.0% |
| Q4 2020 | $390,000 | – | 11,956 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |